SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease
Clinical trial NCT05900882 · RECRUITING
Trial details
- NCT number
- NCT05900882
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-15
- Primary completion
- 2025-08-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.